Global Molecular Modelling Market Insights Forecasts to 2030

• The Global Molecular Modelling Market Size was valued at USD 6.5 Billion in 2021.
• The Market is Growing at a CAGR of 20.1% from 2021 to 2030
• The Worldwide Molecular Modelling Market Size is expected to reach USD 7.8 Billion by 2030
• Asia Pacific is expected To Grow the fastest during the forecast period

The Global Molecular Modelling Market is expected to reach USD 7.8 Billion by 2030, at a CAGR of 20.1% during the forecast period 2021 to 2030.

Molecule modelling software, commonly referred to as drug design software, has the ability to create innovative medications and proteins for the biotechnology and pharmaceutical industries. These programmes are used to analyse molecular models of gene sequences, as well as the three-dimensional structures of proteins and genes.

Impact of COVID 19 On Global Molecular Modelling Market

The COVID 19 pandemic has impacted the global molecular modelling market in a positive way. All steps if drug development has resulted in the molecular modelling procedures which have severely disrupted. In fact, it has forced various key market players and clinical research organizations to put some or all of their research activities on hold. Despite this, many sponsors are still coming up with new ways through which they can start their programs by taking some important decisions.

Key Market Drivers

The growth of the global molecule modelling market is mainly propelled by certain factors like increasing drug development, rising investments in research and development by biotechnology and pharmaceutical companies, technological advancements in drug design. Apart from this, the increasing cases of chronic ailments creates huge growth opportunity in the market. Moreover, the development of new drugs with therapeutic applications is an important step in the pharma industry

Key Market Challenges

The high cost associated with the molecular modelling software and the shortage of skilled healthcare professionals are going to hamper the global molecular modelling market. Due to the high cost invested in the software, many companies do not prefer adopting it for their daily working process. This is an another factor which acts as a significant market barrier.

Market Segmentation

Product Insights

Software segment is dominating the market with the largest market share over the forecast period

On the basis of product, the global molecular modelling market is segmented into software and services. Among these, the software segment is dominating the market with a largest market share over the forecast period. The growth is attributed to the increasing number of software tools launched for molecular modelling as well as visualization. Apart from this, the increasing number of companies associated with developing molecular modelling software is anticipated to contribute over the segmental growth.

Application Insights

Drug development segment accounted the highest market share over the forecast period

On the basis of application, the global molecular modelling market is segmented into drug development, drug discovery, and others. Among these, the dug development segment accounted the highest market share over the forecast period. The increasing prevalence of various health issues and rising resistance against existing medicines are increasing the demand of identifying new drug targets. The average cost of manufacturing new drug molecules and the time taken to continue the research technology are very high due to which many pharmaceutical companies are using molecular modelling techniques for the drug development which result it into the segmental growth.

End User Insights

Pharmaceutical and biotechnology segment holds the highest market share over the forecast period

Based on the end user, the global molecular modelling market is segmented into pharmaceutical and biotechnology companies, research and academic centers, others. Among these, the pharmaceutical and biotechnology segment holds the highest market share over the forecast period. The increasing research and development activities in the drug Discovery and development are increasing the adoption of molecular modelling by Pharmaceutical and Biotechnology companies which is anticipated to drive the segmental growth.

Regional Insights

North America is dominating the market with the largest market share over the forecast period

North America is dominating the market with the largest market share over the forecast period. The growth of the region is attributed to the increasing adoption of the products. Apart from this the region has witness the strong presence of prominent Research institutes and academic organisations promoting the open access for research scientists which contributes towards the growth of the regional market.

Asia Pacific, on the other hand will witness the fastest market growth over the forecast period. This is due to the factors like the increasing disposable income, increasing number of contract Research Organisation, development in the Healthcare infrastructure, and the increasing number of Research Institutes. Not only this there has been the rise in the number of clinical trials related to the research of protein structures bio pharmaceuticals and computational Biology which is anticipated to boost the growth of the regional market.

Recent Market Developments

• In April 2021, Accelera Ltd has introduced a new version of ACEMD which is its molecular dynamics simulation software.

List of Key Companies

• Dassault Systèmes
• Crown Bioscience Inc
• Leadscope, Inc
• Chemical Computing Group Ulc
• Nimbus Therapeutics
• Schrödinger, Inc
• Genedata Ag
• Biognos Ab
• Compugen Ltd
• Acellera ltd.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Molecular Modelling Market based on the below-mentioned segments:

Molecular Modelling Market, Product Analysis

• Software
• Services

Molecular Modelling Market, Application Analysis

• Drug Development
• Dug Discovery
• Others

Molecular Modelling Market, End User Analysis

• Pharmaceutical & Biotechnology Companies
• Research and Academic Centers
• Others

Molecular Modelling Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa